What is Gilead Sciences's accounts payable?

Gilead Sciences (GILD) reported accounts payable of $645M in Q1 2026.

How has Gilead Sciences's accounts payable changed year-over-year?

Gilead Sciences's accounts payable decreased by 12.5% year-over-year, from $737M to $645M.

What is the long-term trend for Gilead Sciences's accounts payable?

Over 5 years (2020 to 2025), Gilead Sciences's accounts payable has grown at a -3.3% compound annual growth rate (CAGR), from $844M to $715M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Gilead Sciences GILD Accounts Payable

Accounts Payable at other companies

Bristol-Myers SquibbBMY

$4.16B-23.4%

IncyteINCY

$250.4M+3.9%

AnaptysBio, Inc.ANAB

$7.52M+22.8%

Iovance Biotherapeutics, Inc.IOVA

$37.45M+31.5%

CelcuityCELC

$10.45M+5.3%

Vir Biotechnology, Inc.VIR

$5.45M+46.2%

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$166.77B+15.4%

Enterprise value$181.31B+10.3%

P/E18.1×-4.8×

P/S5.6×+0.6×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's accounts payable?: Gilead Sciences (GILD) reported accounts payable of $645M in Q1 2026.
How has Gilead Sciences's accounts payable changed year-over-year?: Gilead Sciences's accounts payable decreased by 12.5% year-over-year, from $737M to $645M.
What is the long-term trend for Gilead Sciences's accounts payable?: Over 5 years (2020 to 2025), Gilead Sciences's accounts payable has grown at a -3.3% compound annual growth rate (CAGR), from $844M to $715M.
What does accounts payable mean?: Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.